Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Authors
Keywords
Schizophrenia, Affective disorders, Glutamate, NMDA receptor, Glycine transporter, Cognition
Journal
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Volume 263, Issue 5, Pages 367-377
Publisher
Springer Nature
Online
2013-03-01
DOI
10.1007/s00406-013-0399-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Is D-Cycloserine a Prodrug for D-Serine in the Brain?
- (2012) Mao Horio et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Evaluation of the Effects of Bitopertin (RG1678) on Cardiac Repolarization: A Thorough Corrected QT Study in Healthy Male Volunteers
- (2012) Carsten Hofmann et al. CLINICAL THERAPEUTICS
- Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice
- (2012) Mao Horio et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target
- (2012) Celia Goeldner et al. NEUROPHARMACOLOGY
- mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
- (2012) Shigeyuki Chaki et al. NEUROPHARMACOLOGY
- Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine
- (2012) Mao Horio et al. PLoS One
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- (2012) D. C. Javitt et al. SCHIZOPHRENIA BULLETIN
- Plasma levels of D-serine in Brazilian individuals with schizophrenia
- (2012) Marilia A. Calcia et al. SCHIZOPHRENIA RESEARCH
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Serine racemase and the serine shuttle between neurons and astrocytes
- (2011) Herman Wolosker BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
- (2011) Shigeyuki Chaki et al. CURRENT PHARMACEUTICAL DESIGN
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
- (2011) Kenji Hashimoto et al. CURRENT PHARMACEUTICAL DESIGN
- Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression
- (2011) Brice Campo et al. JOURNAL OF NEUROGENETICS
- Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice
- (2011) Mao Horio et al. NEUROCHEMISTRY INTERNATIONAL
- Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
- (2011) Hiroyuki Koike et al. NEUROPHARMACOLOGY
- Metabotropic glutamate receptors as therapeutic targets for schizophrenia
- (2011) Paige N. Vinson et al. NEUROPHARMACOLOGY
- Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
- (2011) Daniela Alberati et al. NEUROPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism
- (2011) Joseph R. Moskal et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Roles of glutamate signaling in preclinical and/or mechanistic models of depression
- (2011) Kenichi Tokita et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
- (2010) Colleen M. Niswender et al. Annual Review of Pharmacology and Toxicology
- N- methyl-D-aspartate Glutamate Receptor Antagonists and the Promise of Rapid-Acting Antidepressants
- (2010) John H. Krystal ARCHIVES OF GENERAL PSYCHIATRY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered
- (2010) Ian Hindmarch et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia
- (2010) Emmanuel Pinard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression
- (2010) Shang-Feng Gao et al. NEUROSCIENTIST
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- The role of glutamate on the action of antidepressants
- (2010) Kenji Hashimoto PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Glutamatergic Modulators: The Future of Treating Mood Disorders?
- (2010) Carlos Zarate et al. HARVARD REVIEW OF PSYCHIATRY
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Emerging role of glutamate in the pathophysiology of major depressive disorder
- (2009) Kenji Hashimoto BRAIN RESEARCH REVIEWS
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- NMDA- and -Amyloid1-42-Induced Neurotoxicity Is Attenuated in Serine Racemase Knock-Out Mice
- (2009) R. Inoue et al. JOURNAL OF NEUROSCIENCE
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
- (2009) L Verrall et al. MOLECULAR PSYCHIATRY
- Mechanism of differential control of NMDA receptor activity by NR2 subunits
- (2009) Marc Gielen et al. NATURE
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania
- (2008) Dost Öngür et al. BIOLOGICAL PSYCHIATRY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Synthesis and Biological Evaluation ofd-Amino Acid Oxidase Inhibitors
- (2008) Dana Ferraris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)
- (2008) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now